European Journal of Cancer
Volume 46, Issue 8 , Pages 1445-1455 , May 2010

Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells

  • Amélie Rebillard

      Affiliations

    • EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France
    • New address: Laboratoire Physiologie M2S, UFR-APS, Université de Rennes 2, Campus La Harpe, Avenue Charles Tillon, Rennes F-35044, France.
    • ,
  • Sandrine Jouan-Lanhouet

      Affiliations

    • EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France
    • ,
  • Elodie Jouan

      Affiliations

    • EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France
    • ,
  • Patrick Legembre

      Affiliations

    • EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France
    • ,
  • Mathieu Pizon

      Affiliations

    • CNRS UMR 5164, University of Bordeaux 2, Bordeaux F-33076, France
    • ,
  • Odile Sergent

      Affiliations

    • EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France
    • ,
  • David Gilot

      Affiliations

    • EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France
    • ,
  • Xavier Tekpli

      Affiliations

    • EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France
    • ,
  • Dominique Lagadic-Gossmann

      Affiliations

    • EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France
    • ,
  • Marie-Thérèse Dimanche-Boitrel

      Affiliations

    • EA 4427 SeRAIC, Faculty of Pharmacy, University of Rennes 1, IFR 140 GFAS, Rennes F-35043, France
    • Corresponding Author InformationCorresponding author: Address: EA 4427 SeRAIC, Université de Rennes 1, Faculté de Pharmacie, 2 Av du Pr Léon Bernard, Rennes F-35043, France. Tel.: +33 223234837; fax: +33 223234794.

Received 23 October 2009 ,Revised 20 January 2010 ,Accepted 26 January 2010.

References 

  1. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265–7279
  2. Wang K, Lu J, Li R. The events that occur when cisplatin encounters cells. Coord Chem Rev. 1996;151:53–88
  3. Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J Biol Chem. 1999;274:7987–7992
  4. Kischkel FC, Hellbardt S, Behrmann I, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995;14:5579–5588
  5. Scheel-Toellner D, Wang K, Singh R, et al. The death-inducing signaling complex is recruited to lipid rafts in Fas-induced apoptosis. Biochem Biophys Res Commun. 2002;297:876–879
  6. Hueber AO, Bernard AM, Herincs Z, Couzinet A, He HT. An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes. EMBO Rep. 2002;3:190–196
  7. Gajate C, Mollinedo F. The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood. 2001;98:3860–3863
  8. Lacour S, Hammann A, Grazide S, et al. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res. 2004;64:3593–3598
  9. Grassme H, Jekle A, Riehle A, et al. CD95 signaling via ceramide-rich membrane rafts. J Biol Chem. 2001;273:20589–20596
  10. Algeciras-Schimnich A, Shen L, Barnhart BC. Molecular ordering of the initial signaling events of CD95. Mol Cell Biol. 2002;22:207–220
  11. Chakrabandhu K, Herincs Z, Huault S, et al. Palmitoylation is required for efficient Fas cell death signaling. EMBO J. 2007;26:209–220
  12. Parlato S, Giammarioli AM, Logozzi M, et al. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J. 2000;19:5123–5134
  13. Hébert M, Potin S, Sebbagh M. Rho-ROCK-dependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells. J Immunol. 2008;181:5963–5973
  14. Rebillard A, Tekpli X, Meurette O, et al. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res. 2007;67:7865–7874
  15. Fais S, De Milito A, Lozupone F. The role of FAS to ezrin association in FAS-mediated apoptosis. Apoptosis. 2005;10:941–947
  16. Ridley AJ. Rho proteins: linking signaling with membrane trafficking. Traffic. 2001;2:303–310
  17. Shaw RJ, Henry M, Solomon F, Jacks J. RhoA-dependent phosphorylation and relocalization of ERM proteins into apical membrane/actin protrusions in fibroblasts. Mol Biol Cell. 1998;9:403–419
  18. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003;4:446–456
  19. Odaka C, Sanders ML, Crews P. Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway. Clin Diagn Lab Immunol. 2000;7:947–952
  20. Posey SC, Bierer BE. Actin stabilization by jasplakinolide enhances apoptosis induced by cytokine deprivation. J Biol Chem. 1999;274:4259–4265
  21. Janmey PA. The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev. 1998;78:763–781
  22. Zeidan YH, Jenkins RW, Hannun YA. Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway. J Cell Biol. 2008;181:335–350
  23. Ivetic A, Ridley AJ. Ezrin/radixin/moesin proteins and Rho GTPase signaling in leucocytes. Immunology. 2004;112:165–176
  24. Lozupone F, Lugini L, Matarrese P, et al. Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin. J Biol Chem. 2004;279:9199–9207
  25. Yonemura S, Matsui T, Tsukita S. Rho-dependent and -independent activation mechanisms of ezrin/radixin/moesin proteins: an essential role for polyphosphoinositides in vivo. J Cell Sci. 2002;115:2569–2580
  26. Subauste MC, Von Herrath M, Benard V, et al. Rho family proteins modulate rapid apoptosis induced by cytotoxic T lymphocytes and Fas. J Biol Chem. 2000;275:9725–9733
  27. Zeng HH, Lu JF, Wang K. The effect of cisplatin and transplatin on the conformation and association of F-actin. Cell Biol Int. 1995;19:491–497
  28. Ndozangue-Touriguine O, Hamelin J, Breard J. Cytoskeleton and apoptosis. Biochem Pharmacol. 2008;76:11–18
  29. Yang Z, Schumaker LM, Egorin MJ, et al. Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis. Clin Cancer Res. 2006;12:5817–5825
  30. Rao J, Li N. Microfilament actin remodeling as a potential target for cancer drug development. Curr Cancer Drug Tar. 2004;4:345–354
  31. Timmer T, de Vries EG, de Jong S. Fas receptor-mediated apoptosis: a clinical application?. J Pathol. 2002;196:125–134
  32. Spierings DC, de Vries EG, Vellenga E, de Jong S. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line. Cell Death Differ. 2003;10:808–822

PII: S0959-8049(10)00082-1

doi: 10.1016/j.ejca.2010.01.034

European Journal of Cancer
Volume 46, Issue 8 , Pages 1445-1455 , May 2010

Article Tools

* Image Usage & Resolution